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eral patient characteristics and incidence of AF in the three groups is shown in the Table. 
Right atrial pacing significantly reduced the incidence of postoperative AF. 
General Patient Characteristics 
Group 1 Group 2 Group 3 
Number of pts 41 43 43 
% male 56 64 59 
Age (yrs) 69 67 67 
LVEF 47 48 52 
Pump time (min) 121 129 124 
% beta blocker 29 30 21 
Heart rate (bpm) 84 103 (paced)* 104 (paced)* 
P wave duration 91 95 87 
Surgery: 
% valve 26 21 24 
% coronary 72 77 69 
% both 2 2 7 
Number of AF episodes 16 (39%) 7 (16%)* 16 (37%) 
* p < 0.05 versus Group 1 and/or Group 3 
Patients on beta blocker therapy had significantly less AF in each group. Age > 66 and 
history of AF were predictors of AF by multiple logistic analysis. 
Conclusions: 1) Continuous right atrial pacing significantly reduced (45%) the incidence 
of postoperative AF compared to control. 2) Biatriai pacing did not reduce the incidence 
of postoperative AF in this series of pts. 
10:36 a.m. 
1090MP-129 Oofet i l ide for  Atr ia l  F ibr i l lat ion:  Worth Trying Even 
When Other Class III Agents Have Failed 
Jav Curwin, Robed Coyne, Kelly Shea, Oren Bemheim, John Banas, Stephen Winters, 
Morristown Memorial Hospital Morristown, New Jersey, 
Limited information is available regarding the efficacy of dofetilide(D) in patients(pts) with 
atrial arrhythmias treated unsatisfactorily with other Class Ill antiarrhythmic (AA) drugs. 
Thus, we evaluated 43 consecutive pts (27 men; mean 62 yrs) treated with D over a 12 
month period. Indications included: PAF - 34; atrial tachycardia (AT) - 7; atrial flutter (AFI) 
- 2. Coexisting cardiac diseases included: CAD-10 pts; idiopathic cardiomyopathy-6; con- 
genital-3; prosthetic valve-2; myxoma-1; none- 21. Pts were previously treated with 1.7 +/ 
- 1.2 AA drugs. Twenty seven pts had prior unsatisfactory exposure to >1 Class III agents 
(sotalol-23, amiodarone-8, azimilide-2), in-hospital loading with D over a >3 day period 
was based upon creatinine clearance with the dose reduced as needed for prolonged 
QTc. Efficacy was defined as no arrhythmia recurrence or patient sensation of marked 
reduction in frequency. 
Results: D was effective in 18/43 pts (42%) over 235+/-114 days. D was discontinued for 
inefficacy in 22/43 pts (51%), and for side effects in 3/43 pts(7%)[QTc>500 ms despite 
dose reduction- 2, unexplained syncope-I]. Self-limited torsades de pointas (TDP) 
occurred in 1 pt with a long QTc and 1 pt with inefficacy. No sustained TDP, stroke, MI or 
death occurred. No QT prolongation requiring dose reduction or cessation occurred after 
hospital discharge. The mean maintenance dose of D was 409 +#156 mg q12h. Of the 
14 pts on lower doses (250 mg bid in 8; 125 mg bid in 6 pts) because of reduced croati- 
nine clearance or long QTc, D was effective in 4(28%). By indication, benefit was seen in 
15/34 (44%) pts with PAl=, 2/2 (100%) with AFI, 1/7(14%) with AT. Of the 27 pts previously 
treated with class III AA, D was effective in 10(37%), ineffective in 15 (56%) and discon- 
tinued due to intolerance in 2 (7%), 
Conclusions: 1. D may have substantial benefit in suppressing PAF despite prior ineffi- 
cacy or poor toleration of other AA drugs, including class III agents. 2, D is well tolerated 
and rarely requires cessation for noncardiac side effects. 3. Although commonly required 
during initial loading, dose reductions are infrequent once steady state is achieved. 4. D 
may he less effective for atrial tachycerdias. 
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1090MP-130 Verapemil Around Electrical Cardioversion of Persistent 
Atr ial  F ibr i l lat ion:  Results From the VeRAF Study 
Giovanni L. Botto. Giuseppina Belotti, Antonio Cirb, Vigilio Ziacchi, Masslmo Romano, 
Antonio Sagone, Alessandro Politi, Massimo Pale, Daniela Barbieri, Francasco Lo Presti, 
on behalf of The VeRAF Study Group, St Anna Hospital, Como, Italy, 
Background. Atrial fibrillation (AF) is a seif-pemistant arrhythmia due to a remodeling pro- 
cess caused by intracellu~ar calcium overload. Calcium blockers could theoretically limit 
this phenomenon thus leading to a better outcome after cardioversion. 
Methods. 214 patients (pts) (age 68¢9 years) with persistent AF (duration 154±105 
days), were randomized to standard therapy (STD) (N=108) or STD + VER 80 mg t.i.d. 
(N=106), associated to anticoagulation, 1 month before and after EC (4 pts excluded). 
No antiarrhythmic drugs were given. In 6 (6%) Lots in VER group, and in 47 (44%) pts in 
STD, additional digoxin (DIG) was given to control venthcular ate (p<0.0001). Were end- 
points of the study the reversion to sinus rhythm (SR) before EC, the inability to stop AF 
(EC Failure), early relapse of AF within 7 day after EC (ERAF), late relapse between 8-30 
days after EC (LRAF), SR 1 month after EC (SR). 
Results. The two groups were comparable in terms of the mean clinical variables consid- 
ered. The results are in table 1. 
Immediate recurrence (within 1 h) were lower in VER compared to STD (3/72, 4% vs 18/ 
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84, 21%; p=O.004). There was no difference between pts who were taken or not DIG in 
STD group. VER regimen was 40 t.i.d, in 14/106 (13%) pts because of dyspnea (5 pts), 
bradycardia (4 pts), fatigue (5 pts). 
Conclusion. Stand alone VER around EC is effective in reducing early recurrence of AI£ 
The effect is maximum for immediate recurrence reduction. Concomitant use of DIG in 
pts not treated with VER does not interfere with EC outcome. 
Reversion SR EC Failure ERAF LRAF SR 
VER 20/103 (19%) 11/83 (13%) 19/72 (26%) 7/72 (10%) 46/72 (64%) 
STD 10/107 (9%) 13/97 (13%) 51/84 (61%) 9/84 (11%) 24/84 (29%) 
p value 0.059 NS <0.0001 NS <0.001 
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1091-103 Does Trensmural Reentry Exist After Near-Def ibr i l lat ion-  
Thresho ld  Shocks: Three-Dimensional Mapping of  
Ventricular Defibr i l lat ion 
Nieon ChattiDakorn, Parwis C. Fotuhi, Siriporn C. Chattipakom, Raymond E. Ideker, 
University of Alabama at Birmingham, Birmingham, Alabama. 
Following shocks of a strength with 50% defibrillation success (DFT50), recent studies 
showed that the first several post-shock cycles always arose focally, Since those studies 
performed only epicardial mapping, it has been debated that transmural or endocardial 
reentry may exist. We tested this hypothesis by mapping the ventricles in 3 dimensions 
(3-0). Methods end Results: In 6 pigs, 60-84 epoxy-fiberglass (0.7-ram diameter) nee- 
dles (6 silver electrodes, 2-mrn spacing) were inserted into the LV 3-5 mm apart around 
the apex and 5-10 mm apart near the base. Ten DFT50 shocks (RV~SVC, biphasic, 6/4 
ms) were delivered after 10 sec of VF, Activation after each shock was mapped and ana- 
lyzed by animating dV/dt of electrograms. Intarcycle interval (ICI, time between succes- 
sive postshcok cycles) and wavefront conduction time (WCT, time between the earliest 
and latest activation of a cycle) were determined for the first 5 post-shock cycles. All 
post-shock cycles arose focally from the apex and no reentry was observed either trans- 
rnurally or endocardially. The ICI and WCT of cycle 1 were not different between suc- 
cessful (SDF) and failed (FDF) shocks. However, starting at cycle 2, ICI was longer, and 
WCT was shorter for S than F. Conclusion: Following near DFT50 shocks, a focus is the 
3-D pattern of immediate post-shock activations. Rapid, repetitive activation fronts aris- 
ing focally from the apex causing shod ICI and long WCT of successive cycles are 
responsible for failed defibrillation. 
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1091-104 Increased Cycle Length Variability During Ventricular 
Fibrillation: A Novel Predictor of Arrhythmia 
Recurrence 
Hisashi Yokoshiki, Tetsuro Kohya, Minoru Sato, Koji Sasaki, Akihiko Yotsukura, 
Masayuki Sakurai, Akira Kitabatake, Hokkaido University Graduate School of Medicine, 
Sapporo, Japan, Hokko Memorial Hospital, Sapporo, Japan. 
The electrophysiological substrate determines the characteristics of ventricular fibrillation 
(VF). We thus hypothesized that enhanced variability of VF cycle length (VFCL) reflects 
unstable electrical substrate, thereby predicting the recurrence of VF or ventricular tachy- 
cardia (VT). To test this, consecutive 24 patients who underwent ICD implantation using 
single transvenous lead placed at right ventricular apex, were enrolled. In VF induced for 
defibrillation testing, mean successive differences (MSD) of VFCL and coefficient of vari- 
ations of the VFCL (CVFF) (SD'100/mean VFCL) were calculated. By comparing the first 
VF to the second one, good repeatability (Bland-Airman analysis) of MSD and CVFF in 
each patient was confirmed, and these indexes significantly corrslated with QTc disper- 
sion. During the follow-up of 20 ± 9 months, ten patients had recurrence of VF/VT, The 
MSD and CVFF in recurrence (R) group (n = 10) were significantly increased compared 
to those in non-recurronce (N) group (n = 14) (MSD and CVFF : 31 ± 10" and 15 ± 4* in 
group R; 17 ± 8 and 9 ± 4 in group N; *P < 0,005 vs. group N). Age, left ventricular ejec- 
tion fraction (LVEF) and use of amiodarone were not different between groups. Kaplan- 
